Form 8-K ImmunoGen, Inc. For: Dec 17

Go back to Form 8-K ImmunoGen, Inc. For: Dec 17

Immunogen Inc. (IMGN) PT Raised to $4 at SVB Leerink

December 17, 2019 11:15 AM EST

SVB Leerink analyst Jonathan Chang raised the price target on Immunogen Inc. (NASDAQ: IMGN) to $4.00 (from $2.00) while maintaining a Market Perform rating.

SORAYA opens door for accelerated approval; top-line data in mid-2021.... More